| Bradford Optical | |
|
331 Upper Pln, Bradford, VT 05033-9207 | |
| (802) 222-4543 | |
| Not Available |
| Full Name | Bradford Optical |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 331 Upper Pln, Bradford, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376282053 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Nicholas Pittman |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1134552755 PECOS PAC ID: 3072749738 Enrollment ID: I20131202001408 |
News Archive
Influenza strikes five to 15 percent of the population and is estimated to cost the U.S. economy a hefty $90 million per year. If researchers can improve the understanding of how environmental conditions affect the ability of the influenza virus to survive and infect others while it is airborne, they may be able to help improve prediction and control of its spread.
In the 2,500+ years that have passed since acupuncture was first used by the ancient Chinese, it has been used to treat a number of physical, mental and emotional conditions including nausea and vomiting, stroke rehabilitation, headaches, menstrual cramps, asthma, carpal tunnel, fibromyalgia and osteoarthritis, to name just a few.
Thomas Jessell, PhD, the Claire Tow Professor of Motor Neuron Disorders in the Departments of Neuroscience and of Biochemistry and Molecular Biophysics at Columbia University, is the recipient of the 2014 Neuroscience Prize of The Gruber Foundation.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
In a new study, researchers at Uppsala University have found evidence of a new principle for how epigenetic changes can occur. The principle is based on an enzyme, tryptase, that has epigenetic effects that cause cells to proliferate in an uncontrolled manner.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bradford Optical Po Box 325, Bradford, VT 05033-0325 Ph: (802) 222-4543 | Bradford Optical 331 Upper Pln, Bradford, VT 05033-9207 Ph: (802) 222-4543 |
News Archive
Influenza strikes five to 15 percent of the population and is estimated to cost the U.S. economy a hefty $90 million per year. If researchers can improve the understanding of how environmental conditions affect the ability of the influenza virus to survive and infect others while it is airborne, they may be able to help improve prediction and control of its spread.
In the 2,500+ years that have passed since acupuncture was first used by the ancient Chinese, it has been used to treat a number of physical, mental and emotional conditions including nausea and vomiting, stroke rehabilitation, headaches, menstrual cramps, asthma, carpal tunnel, fibromyalgia and osteoarthritis, to name just a few.
Thomas Jessell, PhD, the Claire Tow Professor of Motor Neuron Disorders in the Departments of Neuroscience and of Biochemistry and Molecular Biophysics at Columbia University, is the recipient of the 2014 Neuroscience Prize of The Gruber Foundation.
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that two oral presentations and two abstracts were delivered at the 52nd Annual Meeting of the American Society of Hematology in Orlando, Florida. The presentations and abstracts highlighted clinical and preclinical progress with GlycoMimetics's lead compound GMI-1070, now in Phase 2 clinical trials in sickle cell crisis.
In a new study, researchers at Uppsala University have found evidence of a new principle for how epigenetic changes can occur. The principle is based on an enzyme, tryptase, that has epigenetic effects that cause cells to proliferate in an uncontrolled manner.
› Verified 2 days ago
Jones Family Eyecare Optometrist Medicare: Not Enrolled in Medicare Practice Location: 331 Upper Pln, Bradford, VT 05033 Phone: 802-222-4543 Fax: 802-222-4503 | |
Dr. Nicholas A Pittman, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 331 Upper Pln Unit 2, Bradford, VT 05033 Phone: 802-222-4543 | |
Dr. Andrew M. Jones, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 331 Upper Pln, Bradford, VT 05033 Phone: 802-222-4543 Fax: 802-222-4503 | |
Dr. Reginald Henry Jones, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 331 Upper Pln, Bradford, VT 05033 Phone: 802-222-4543 Fax: 802-222-4503 | |
Bradford Optical, Plc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 331 Upper Pln, Bradford, VT 05033 Phone: 802-222-4543 Fax: 802-222-4503 |